Reaction

Nephritic Syndrome reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 305 reports · 6 co-occurring drugs

As of the last recalculation, Nephritic Syndrome appears in 305 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE (PRR 79.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Esomeprazole Magnesium Capsule, Delayed Release1679.479.4
Esomeprazole Magnesium Delayed Release Capsules1679.479.4
Esomeprazole Magnesium Dihydrate1679.079.1
Octreotide Acetate2560.660.6
Sunitinib Malate2547.247.2
Everolimus2739.639.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.